Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (8085)	5/15/1998 11:29:00 AM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

Frostman.........The question is has Vivus been holding back waiting for FDA approval of the new plant....If the MCA approval on the new plant is only good for the UK at this time. Then any supplies for startup in Brazil, Argentina, Switzerland, S. Korea and now Sweden have to come from the old plant...as well as supply the USA. The short term impact of Viagra has cut back script demand in the US but that can pickup quickly..... Viagra has proven that there is a huge market to address impotence. The aging population will only increase the market size. Let's see what Vivus management does as soon as the new plant receives FDA approval.....